News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,847 Results
Type
Article (87083)
Company Profile (704)
Press Release (768043)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232918)
Career Advice (4135)
Deals (39772)
Drug Delivery (132)
Drug Development (91155)
Employer Resources (200)
FDA (18222)
Job Trends (17377)
News (397051)
Policy (39864)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (125)
Alzheimer's disease (1623)
Antibody-drug conjugate (ADC) (195)
Approvals (18198)
Artificial intelligence (422)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (141)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (416)
Cancer (3318)
Cardiovascular disease (266)
Career advice (3544)
Career pathing (34)
CAR-T (219)
CDC (43)
Cell therapy (605)
Cervical cancer (27)
Clinical research (74637)
Collaboration (1198)
Company closure (4)
Compensation (804)
Complete response letters (43)
COVID-19 (2924)
CRISPR (71)
C-suite (427)
Cystic fibrosis (126)
Data (3390)
Decentralized trials (2)
Denatured (56)
Depression (86)
Diabetes (392)
Diagnostics (7018)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (197)
Drug pricing (165)
Drug shortages (36)
Duchenne muscular dystrophy (172)
Earnings (98537)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131776)
Executive appointments (936)
FDA (20303)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1067)
Gene editing (154)
Generative AI (42)
Gene therapy (478)
GLP-1 (971)
Government (5314)
Grass and pollen (7)
Guidances (325)
Healthcare (20922)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (200)
Immuno-oncology (17)
Indications (43)
Infectious disease (3132)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (143)
Interviews (813)
IPO (17911)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (64)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (461)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (504)
MASH (112)
Medical device (14785)
Medtech (14797)
Mergers & acquisitions (22640)
Metabolic disorders (1013)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (168)
Neuropsychiatric disorders (48)
Neuroscience (2449)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (52)
Obesity (510)
Opinion (298)
Ovarian cancer (109)
Pain (137)
Pancreatic cancer (137)
Parkinson's disease (209)
Partnered (27)
Patents (355)
Patient recruitment (215)
Peanut (55)
People (65889)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23020)
Phase II (32397)
Phase III (24406)
Pipeline (2273)
Policy (266)
Postmarket research (3554)
Preclinical (10400)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (562)
Real estate (7404)
Recruiting (76)
Regulatory (27446)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (112)
Series A (177)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4310)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (78)
The Weekly (98)
Vaccines (967)
Venture capital (62)
Weight loss (351)
Women's health (53)
Worklife (20)
Date
Today (106)
Last 7 days (637)
Last 30 days (2725)
Last 365 days (33935)
2025 (21386)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (288)
Arkansas (14)
Asia (50660)
Australia (8899)
California (8414)
Canada (2568)
China (771)
Colorado (360)
Connecticut (377)
Delaware (227)
Europe (116320)
Florida (1264)
Georgia (288)
Hawaii (3)
Idaho (67)
Illinois (768)
India (37)
Indiana (408)
Iowa (19)
Japan (252)
Kansas (119)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1170)
Massachusetts (6390)
Michigan (287)
Minnesota (521)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (93)
New Hampshire (75)
New Jersey (2335)
New Mexico (31)
New York (2318)
North Carolina (1305)
North Dakota (10)
Northern California (3699)
Ohio (268)
Oklahoma (17)
Oregon (48)
Pennsylvania (1792)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (40)
South Dakota (1)
Southern California (3160)
Tennessee (136)
Texas (1313)
United States (31519)
Utah (250)
Virginia (229)
Washington D.C. (81)
Washington State (726)
West Virginia (4)
Wisconsin (89)
There are 855,847 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2
August 20, 2025
·
5 min read
Press Releases
Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
August 20, 2025
·
2 min read
Press Releases
TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension
August 20, 2025
·
10 min read
Press Releases
New Data Confirms Bioequivalence of Relexxii® and Concerta® in Healthy Adults¹
August 20, 2025
·
3 min read
Press Releases
n-Lorem Foundation Publishes Study Showing Targeted ASO Therapy Restores GBE1 Protein in APBD Patient Cells
August 20, 2025
·
5 min read
Press Releases
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
August 20, 2025
·
4 min read
Press Releases
Xspray Pharma Submits XS003 to the FDA – The Company’s Second Product Candidate from the HyNap Platform
August 20, 2025
·
2 min read
Press Releases
InnoCare Releases 2025 Interim Results and Business Highlights
August 20, 2025
·
11 min read
Duchenne muscular dystrophy
With Prasad Back at FDA, Capricor To Fight CRL for DMD Cardiomyopathy
Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the regulator that it got it wrong. Capricor plans to resubmit the application based on deramiocel’s existing dataset.
August 20, 2025
·
7 min read
·
Heather McKenzie
Tariffs
Tariffs and MFN Policy Power a Broad, Confusing Pharma War
The Trump administration’s ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, potentially illegal tactics that leave observers throwing their hands in the air.
August 20, 2025
·
4 min read
·
Dan Samorodnitsky
1 of 85,585
Next
